Robb Kociol is a Senior Medical Director at Cytokinetics since July 2021, following an Executive Director role at Boehringer Ingelheim from September 2019 to July 2021. Kociol served as an Executive Board Member for the Heart Failure Society of America from September 2017 to September 2019 and was a Section Editor for CIRCULATION: Heart Failure during the same period. Additionally, Kociol held the position of Assistant Professor of Medicine at Harvard Medical School from July 2016 to September 2019. Kociol earned an MD from Boston University School of Medicine in 2004 and a BS in Biochemistry from UC San Diego in 1996.
This person is not in any teams
This person is not in any offices